These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23017875)
1. Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification. Wang D; Baudys J; Ye Y; Rees JC; Barr JR; Pirkle JL; Kalb SR Anal Biochem; 2013 Jan; 432(2):115-23. PubMed ID: 23017875 [TBL] [Abstract][Full Text] [Related]
2. Optimization of SNAP-25-derived peptide substrate for improved detection of botulinum A in the Endopep-MS assay. Rosen O; Feldberg L; Dor E; Gura S; Zichel R Anal Biochem; 2017 Jul; 528():34-37. PubMed ID: 28450105 [TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Bioorg Med Chem; 2015 Jul; 23(13):3667-73. PubMed ID: 25913863 [TBL] [Abstract][Full Text] [Related]
4. Improved detection of botulinum neurotoxin type A in stool by mass spectrometry. Wang D; Baudys J; Kalb SR; Barr JR Anal Biochem; 2011 May; 412(1):67-73. PubMed ID: 21276417 [TBL] [Abstract][Full Text] [Related]
5. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay. Wang D; Krilich J; Baudys J; Barr JR; Kalb SR Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998 [TBL] [Abstract][Full Text] [Related]
6. Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry. Wang D; Baudys J; Hoyt KM; Barr JR; Kalb SR Anal Bioanal Chem; 2017 Aug; 409(20):4779-4786. PubMed ID: 28573317 [TBL] [Abstract][Full Text] [Related]
7. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization. Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236 [TBL] [Abstract][Full Text] [Related]
8. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925 [TBL] [Abstract][Full Text] [Related]
9. A new peptide substrate for enhanced botulinum neurotoxin type B detection by endopeptidase-liquid chromatography-tandem mass spectrometry/multiple reaction monitoring assay. Rosen O; Feldberg L; Gura S; Zichel R Anal Biochem; 2015 Mar; 473():7-10. PubMed ID: 25277815 [TBL] [Abstract][Full Text] [Related]
11. Modification and validation of the Endopep-mass spectrometry method for botulinum neurotoxin detection in liver samples with application to samples collected during animal botulism outbreaks. Tevell Ã…berg A; Karlsson I; Hedeland M Anal Bioanal Chem; 2021 Jan; 413(2):345-354. PubMed ID: 33119784 [TBL] [Abstract][Full Text] [Related]
12. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry. Parks BA; Shearer JD; Baudys J; Kalb SR; Sanford DC; Pirkle JL; Barr JR Anal Chem; 2011 Dec; 83(23):9047-53. PubMed ID: 22017298 [TBL] [Abstract][Full Text] [Related]
13. Improved detection of botulinum type E by rational design of a new peptide substrate for endopeptidase-mass spectrometry assay. Rosen O; Feldberg L; Gura S; Zichel R Anal Biochem; 2014 Jul; 456():50-2. PubMed ID: 24721293 [TBL] [Abstract][Full Text] [Related]
14. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies. Kalb SR; Lou J; Garcia-Rodriguez C; Geren IN; Smith TJ; Moura H; Marks JD; Smith LA; Pirkle JL; Barr JR PLoS One; 2009; 4(4):e5355. PubMed ID: 19399171 [TBL] [Abstract][Full Text] [Related]
15. Development of a multiplex Endopep-MS assay for simultaneous detection of botulinum toxins A, B and E. Rosen O; Feldberg L; Yamin TS; Dor E; Barnea A; Weissberg A; Zichel R Sci Rep; 2017 Nov; 7(1):14859. PubMed ID: 29093524 [TBL] [Abstract][Full Text] [Related]
16. From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Boyer AE; Moura H; Woolfitt AR; Kalb SR; McWilliams LG; Pavlopoulos A; Schmidt JG; Ashley DL; Barr JR Anal Chem; 2005 Jul; 77(13):3916-24. PubMed ID: 15987092 [TBL] [Abstract][Full Text] [Related]
17. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay. Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544 [TBL] [Abstract][Full Text] [Related]
18. Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity. Kalb SR; Boyer AE; Barr JR Toxins (Basel); 2015 Aug; 7(9):3497-511. PubMed ID: 26404376 [TBL] [Abstract][Full Text] [Related]
19. Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics. Kalb SR; Goodnough MC; Malizio CJ; Pirkle JL; Barr JR Anal Chem; 2005 Oct; 77(19):6140-6. PubMed ID: 16194071 [TBL] [Abstract][Full Text] [Related]
20. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Schmidt JJ; Stafford RG Appl Environ Microbiol; 2003 Jan; 69(1):297-303. PubMed ID: 12514008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]